JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q1 2021 Results - Earnings Call Transcript

Jazz Pharmaceuticals plc (JAZZ) Q1 2021 Results Earnings Conference Call May 4, 2021, 04:30 PM ET Company Participants Andrea Flynn - Head of Investor Relations Bruce Cozadd - Chairman and Chief Executive Officer Daniel Swisher, Jr. - President and Chief Operating Officer Robert Iannone - Executive Vice President, Research and Development and Chief Medical Officer Renée Galá - Executive Vice President and Chief Financial Officer Kim Sablich - Executive Vice President and General Manager, North America Philip Jochelson - Neuroscience Therapeutic Head Anne Borgman - Hematology and Oncology Therapeutic Head Conference Call Participants Ken Cacciatore - Cowen and Company Jason Gerberry - Bank of America Merrill Lynch Jessica Fye - J.P. Morgan Gary Nachman - BMO Capital Markets David Amsellem - Piper Sandler & Co. David Risinger - Morgan Stanley Balaji Prasad - Barclays Capital Marc Goodman - SVB Leerink Gregg Gilbert - Truist Securities Graig Suvannavejh - Goldman Sachs

For further details see:

Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q1 2021 Results - Earnings Call Transcript